| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2215.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology and Clinical Research Institute, Seoul National University Hospital, Seoul (E-C.S., K.C., K-H.J., M.K., B-W.Y.); Neuroscience Research Institute of Seoul National University Medical Research Center, Seoul (E-C.S., K.C., K-H.J., M.K., B-W.Y.); Department of Neurology, Seoul National Hospital, Seoul (K.C.); Department of Neurology, Ilsan Paik Hospital, Inje University, Ilsan (S-W.J.); and Department of Neurology, Gangwon University, Chunchon (S-H.K.), South Korea. Dr Song and Dr Chu contributed equally to this work.
Reprint requests to Byung-Woo Yoon, MD, PhD, Department of Neurology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea. E-mail bwyoon{at}snu.ac.kr
| Abstract |
|---|
|
|
|---|
Methods Hyperglycemia was induced by intraperitoneal injection of streptozotocin (60 mg/kg) in adult Sprague-Dawley male rats. ICH was induced by stereotaxic infusion of 0.23 U of collagenase into the left striatum. Seventy-two hours after ICH, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining was performed for perihematomal cell death. We also measured brain water content to evaluate edema formation.
Results The serum glucose level of the hyperglycemic group was 394.0±180.3 mg/dL (n=31), and that of the normoglycemic group was 97.5±27.4 mg/dL (n=31). The size of hemorrhage was similar between groups, without any significant difference (n=8 in each group). The brain water content of hyperglycemic rats (n=17) increased in both lesioned (81.0±0.5%) and nonlesioned hemispheres (78.7±0.6%) compared with the normoglycemic group (n=17; lesioned: 78.9±0.8%; nonlesioned: 77.3±1.1%). In the hyperglycemic group, more TUNEL-positive cells were found in the perihematomal regions (n=6).
Conclusions Hyperglycemia caused more profound brain edema and perihematomal cell death in experimental ICH.
Key Words: brain edema hyperglycemia intracerebral hemorrhage neuronal death streptozotocin
| Introduction |
|---|
|
|
|---|
Intracerebral hemorrhage (ICH) represents at least 15% of all strokes in Western populations7 and a considerably higher proportion (20% to 30%) in Asian and black populations.8,9 The prognosis of ICH is poor, often much worse than that of ischemic strokes of similar size.9 Patients with ischemic stroke (up to 30%) will undergo hemorrhagic transformation,10 and a considerable number of ischemic infarct patients after thrombolysis develop hemorrhagic conversion or symptomatic hematoma.11 Brain edema is also usually associated with deterioration in ICH. Many patients can deteriorate because of hematoma expansion or large hematoma and brain edema development.9,1214 However, the exact mechanism of edema formation after ICH is still unknown. Moreover, there is no animal study showing the effect of hyperglycemia on the brain edema associated with ICH.
To investigate the pathogenesis of ICH, various animal models have been developed.1517 In the present study we examined the hypothesis that hyperglycemia may exert its effect on the formation of brain edema and associated perihematomal cell death after ICH.
| Materials and Methods |
|---|
|
|
|---|
Morphometric Measurement of Hemorrhage Volume
Rats were assigned to 2 experimental groups: a normoglycemic group (control; n=8) and a hyperglycemic group treated with streptozotocin (n=8). Three days after the injection of streptozotocin, serum glucose level was obtained by tail vein sampling before and after (measured daily for 2 days) the induction of ICH. Seventy-two hours after the operation, rats were anesthetized by the same methods and killed by decapitation. The brain was removed immediately and fixed with 4% phosphate-buffered paraformaldehyde. Fixed brains were cut coronally through the needle entry site (identifiable on the brain surface), and then serial slices (1 mm thick) both anterior and posterior to the needle entry site were obtained. Digital photographs of the serial slices were taken, and the size of hemorrhage was measured with an image analyzer program (Image Pro-Plus, Media Cybernetics). Total hematoma volume was calculated by summing the clot area in each section and multiplying by the distance between sections.
Measuring Brain Water Contents
Rats were assigned to 2 experimental groups: one group consisting of 17 normoglycemic rats and the other group consisting of 17 hyperglycemic rats. Two days after operation, the brains were harvested, and the cerebellum and the brain stem were removed and then divided into 2 hemispheres along the midline. The wet weight of the hemispheres was measured. The hemispheres were incubated in an oven at 100°C for 24 hours to obtain the dry weight. Water content was expressed as percentage of wet weight; the formula for calculation was as follows: (wet weight-dry weight)/(wet weight)x100.20
TUNEL Assay
Rats used for terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining were killed with an overdose of sodium pentobarbital at 72 hours after collagenase injection (hyperglycemia: n=6; normoglycemia: n=6). The TUNEL procedure for in situ detection of DNA fragmentation was performed.21,22 In brief, air-dried sections were postfixed in 4% paraformaldehyde for 15 minutes at room temperature. After they were washed 3 times in Tris-HCl (pH 7.7), sections were treated with 2% H2O2 for 10 minutes at room temperature to quench endogenous peroxidase activity. Sections were then incubated with terminal deoxynucleotidyl transferase enzyme solution containing 25 mmol/L Tris-HCl (pH 6.6), 200 mmol/L potassium cacodylate, 0.25 mg/mL bovine serum albumin, 2.5 mmol/L CoCl2, 40 µmol/L biotinylated-16-dUTP, and 500 U/mL terminal deoxynucleotidyl transferase (Boehringer-Mannheim) at 37°C for 1 hour. Sections were dipped in 300 mmol/L NaCl and 30 mmol/L sodium citrate for 15 minutes at room temperature to terminate reactions. After sections were washed 3 times in Tris-HCl (pH 7.7) and subsequently blocked with PBS (pH 7.4) containing 10% normal goat serum and 0.3% Triton X-100, biotinylated-16-dUTP was visualized by the avidin-biotin method with 0.05% 3,3'-diaminobenzidine tetrahydrochloride and 0.005% H2O2. Cell density counts were performed on sections lightly counterstained with toluidine blue stain. A single axial section through the center of the hemorrhagic lesion was analyzed. Square sampling regions (300x300 µm) were used for cell counting. Eight sampling regions were placed along the periphery. The TUNEL-positive cells were identified and counted. Total counts in these sampling regions were converted into cell densities for quantification and comparison between treatment groups.
Behavioral Testing
Behavioral testing was performed by 2 individuals blinded to the assignment of rats (total n=28) before and 3 days after ICH with the use of the modified limb placing test, which is a modified version of a test previously described in the literature.23 The test consists of 2 limb-placing tasks that assess the sensorimotor integration of the forelimb and the hind limb by checking responses to tactile and proprioceptive stimulation. First, the rat is suspended 10 cm over a table, and the stretch of the forelimbs toward the table is observed and evaluated as follows: normal stretch, 0 points; abnormal flexion, 1 point. Next the rat is positioned along the edge of the table, and its forelimbs are suspended over the edge of the table and allowed to move freely. Each limb (forelimb, second task; hind limb, third task) is pulled down gently, and retrieval and placement are checked. Finally, the rat is placed toward the table edge to check for lateral placement of the forelimb. The 3 tasks are scored in the following manner: normal performance, 0 point; performance with a delay (2 seconds) and/or incomplete, 1 point; no performance, 2 points. Seven points indicates maximal neurological deficit, and 0 points indicates normal performance.
Statistical Analysis
All data in this study are presented as mean±SD. Data from different animal groups were analyzed by the Mann-Whitney U test and unpaired Student t test. The differences were considered significant at probability values <0.05.
| Results |
|---|
|
|
|---|
|
|
Size of Hemorrhage
Rats infused with 0.23 U of collagenase developed large hemorrhages in the striatum that were evident by 24 hours (Figure 2). The size of hemorrhage was 8.99±4.51 mm3 (n=8) in the hyperglycemic group and 8.87±3.61 mm3 (n=8) in the normoglycemic group (Figure 2) by 72 hours. There was no significant difference between the sizes of hemorrhage between groups (P=1.00, Mann-Whitney U test).
|
Minor intraventricular hemorrhage (IVH) occurred in a few rats (n=3 of 14, normoglycemic group; n=3 of 14, hyperglycemic group), which did not significantly affect the behavioral test results measured at 3 days after ICH induction (modified limb placing test score: 6.4±0.2 in ICH+IVH group, n=6; 6.3±0.4 in ICH only group, n=22; P=0.95, Mann-Whitney U test).
Brain Edema Formation
Brain water content of the lesioned (left) hemisphere was 81.0±0.5% in the hyperglycemic group (n=17) and 78.9±0.8% in the normoglycemic group (n=17) (P<0.01, unpaired t test); brain water content of the nonlesioned (right) hemisphere was 78.7±0.6% in the hyperglycemic group and 77.3±1.1% in the normoglycemic group (P<0.01, unpaired t test; Figure 3). Brain water content of hyperglycemic rats increased in both lesioned and nonlesioned hemispheres compared with the normoglycemic group.
|
TUNEL-Positive Cell Density After ICH
TUNEL staining revealed a high density of positive cells within the hemorrhage lesion itself as well as in the surrounding periphery (Figure 4). Brain sections that were counterstained with toluidine blue showed that the TUNEL-positive cells were not likely to be infiltrating leukocytes (Figure 4). Quantitative analysis showed regional TUNEL-positive cell differences between the groups (n=6). The hyperglycemic group (923.1±74.3 cells per square millimeter) showed significantly more TUNEL-positive cells than the normoglycemic group (301.7±91.5 cells per square millimeter; P<0.01, unpaired t test).
|
| Discussion |
|---|
|
|
|---|
In our study brain edema after ICH with hyperglycemia increased in both lesioned and nonlesioned hemispheres, and this may be more attributable to vasogenic edema. Brain edema is generally divided into cytotoxic and vasogenic types, depending on whether the BBB is intact or disrupted.20,2427 The brain edema of experimental ICH is regarded as a combination of cytotoxic and vasogenic edema. Brain edema forms as a result of BBB disruption and the local generation of osmotically active substances. Brain edema was increased not only in the perihematomal region but also in the more distant structures, even in contralateral basal ganglia, possibly because of increased BBB permeability and diaschisis, in rat ICH models20 and human subjects with ICH.28
Our results revealed that hyperglycemia may aggravate brain edema, culminating in neural cell death around the hematoma, with an increase in TUNEL-positive cells. Collagenase itself, used in this study for the induction of ICH, did not cause cell death in vitro (10 to 15 U /mL).22 Apoptosis is reported to be involved in the pathophysiology of cell death after ICH.22 However, the triggering events that are responsible for initiating the apoptotic cascade after ICH remain to be defined. The activated blood components (eg, thrombin, iron, and heme) may induce high levels of cytokine activity.22,29 Inflammatory cytokines such as tumor necrosis factor-
(TNF-
) and interleukin-1 (IL-1) may be involved in hyperglycemia-induced brain edema. Administration of IL-1 and TNF-
induces opening of the BBB and causes vasogenic brain edema.3032 In vitro studies demonstrated that hyperglycemia increases the secretion of IL-1ß in cultured human aortic endothelial cells.33 Mouse uterine epithelial cells cultured in high glucose showed an increase in TNF-
production via an increase in IL-1ß secretion.34 Acute hyperglycemia increases the level of circulating TNF-
in humans; this effect is more pronounced in patients with impaired glucose tolerance.35
Previous experimental studies have demonstrated that hyperglycemia worsens acute BBB injury after transient forebrain ischemia in rats and accentuates brain edema.5,6,36,37 The summarized speculations for hyperglycemia-induced brain injury are as follows. (1) Free radical formation is increased with hyperglycemia-induced brain injury. The free radicals and nitric oxide increase BBB permeability and brain edema.3840 (2) Hyperglycemia induces bradykinin-mediated brain edema with inflammation. Bradykinin is a potent vasodilator and induces brain edema in animal models41; bradykinin B2 receptors play a role in the formation of vasogenic brain edema in a cold injury model in rats, and B2 receptor antagonist reduces vasogenic edema.42,43 Bradykinin increases BBB permeability and facilitates extravasation by dilation of arterial blood vessels.43 (3) Hyperglycemia exerts its effect on cell death by inducing inflammatory reactions in ICH.44,45 (4) Hyperglycemia causes acute elevation of cytosolic free calcium as a result of increased calcium influx.46,47 Rising calcium concentration in the cytoplasm causes calcium influx into mitochondria and disrupts mitochondrial membrane potential and normal metabolism, leading to cell death. The calcium channel blocker (S)-emopamil reduces brain edema from collagenase-induced hemorrhage in rats, possibly by reducing calcium entry and sodium exchange.48
In summary, our data provide initial evidence that hyperglycemia may aggravate brain edema with neural cell death in an experimental rat ICH model.
| Acknowledgments |
|---|
Received January 21, 2003; revision received May 9, 2003; accepted May 28, 2003.
| References |
|---|
|
|
|---|
2. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat, I: local cerebral blood flow and glucose utilization. Stroke. 1980; 11: 347354.
3. Longstreth WT Jr, Inui TS. High glucose level on hospital admission and poor neurologic recovery after cardiac arrest. Ann Neurol. 1984; 15: 5963.[CrossRef][Medline] [Order article via Infotrieve]
4. Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, Hardy RJ, Grotta JC, Buchan AM. Serum glucose levels and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999; 30: 3439.
5. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier in jury after forebrain ischemia in rats. Stroke. 1993; 24: 111116.
6. de Courten-Myers GM, Kleinholz M, Holm P, DeVoe G, Schmitt G, Wagner KR, Myers RE. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 1992; 21: 120126.[CrossRef][Medline] [Order article via Infotrieve]
7. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001; 344: 14501460.
8. Lo YK, Yiu CH, Hu HH, Su MS, Laeuchli SC. Frequency and characteristics of early seizures in Chinese acute stroke. Acta Neurol Scand. 1994; 90: 8385.[Medline] [Order article via Infotrieve]
9. Sacco RL, Mayer SA. Epidemiology of intracranial hemorrhage. In: Feldmann E, ed. Intracerebral Hemorrhage. Armonk, NY: Futura Publishing Co; 1994: 323.
10. Lyden PD, Zivin JA. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Metab Rev. 1993; 5: 116.[Medline] [Order article via Infotrieve]
11. NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous TPA therapy for ischemic stroke. Stroke. 1997; 28: 21092118.
12. Kaneko M, Tanaka K, Shimada T, Sato K, Uemura K. Long-term evaluation of ultra-early operation for hypertensive intracerebral hemorrhage in 100 cases. J Neurosurg. 1983; 58: 838842.[CrossRef][Medline] [Order article via Infotrieve]
13. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994; 44: 13791384.
14. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke. 2003; 34: 224229.
15. Kaufman HH, Pruessner JL, Bernstein DP, Borit A, Ostrow PT, Cahall DL. A rabbit model of intracerebral hematoma. Acta Neuropathol (Berl). 1985; 65: 381321.
16. Kingman TA, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral mass: description of model, intracerebral pressure changes and neuropathology. J Neuropathol Exp Neurol. 1988; 47: 128137.[Medline] [Order article via Infotrieve]
17. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in the rat. Stroke. 1990; 21: 801807.
18. Nedergaard M, Diemer NH. Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration. Acta Neuropathol (Berl). 1987; 73: 131137.[CrossRef][Medline] [Order article via Infotrieve]
19. Paxinos G, Watson C. The Rat Brain in Stereotactic Coordinates. New York, NY: Academic Press; 1982.
20. Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barriers permeability in rats. J Neurosurg. 1994; 81: 93102.[Medline] [Order article via Infotrieve]
21. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992; 119: 493501.
22. Matsushita K, Meng W, Wang X, Asahi M, Asahi K, Moskowitz MA, Lo EH. Evidence for apoptosis after intracerebral hemorrhage in rat striatum. J Cereb Blood Flow Metab. 2000; 20: 396404.[CrossRef][Medline] [Order article via Infotrieve]
23. Puurunen K, Jolkkonen J, Sirvio J, Haapalinna A, Sivenius J. An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats. Neuropharmacology. 2001; 40: 597606.[CrossRef][Medline] [Order article via Infotrieve]
24. Chu K, Kang DW, Kim DE, Park SH, Roh JK. Diffusion-weighted and gradient-echo MR findings of hemichorea-hemiballism associated with nonketotic hyperglycemia: a hyperviscosity syndrome? Arch Neurol. 2002; 59: 448452.
25. Chu K, Kang DW, Kim HJ, Lee YS, Park SH. Diffusion-weighted imaging abnormalities in Wernickes encephalopathy: reversible cytotoxic edema? Arch Neurol. 2002; 59: 123127.
26. Chu K, Kang DW, Yoon BW, Roh JK. Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch Neurol. 2001; 58: 15691576.
27. Chu K, Kang DW, Kim JY, Chang KH, Lee SK. Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus. Arch Neurol. 2001; 58: 993998.
28. Carhuapoma JR, Barker PB, Hanley DF, Wang P, Beauchamp NJ. Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2002: 23; 13221326.[Medline] [Order article via Infotrieve]
29. Kitaoka T, Hua Y, Xi G, Hoff JT, Keep RF. Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke. 2002; 33: 30123018.
30. Gordon CR, Merchant RS, Marmarou A, Rice CD, Marsh JT, Young HF. Effect of murine recombinant interleukin-1 on brain edema in the rat. Acta Neurochir Suppl. 1990; 51: 268270.[Medline] [Order article via Infotrieve]
31. Megyeri P, Abraham CS, Temesvari P, Kovacs J, Vas T, Speer CP. Recombinant human tumor necrosis factor-
constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett. 1992; 148: 137140.[CrossRef][Medline]
[Order article via Infotrieve]
32. Holmin S, Mathiesen T. Intracerebral administration of interleukin 1ß and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg. 2000; 92; 108120.[Medline] [Order article via Infotrieve]
33. Asakawa H, Miyagawa J, Hanafusa T, Kuwajima M, Matsuzawa Y. High glucose and hyperosmolarity increase secretion of interleukin-1ß in cultured human aortic endothelial cells. J Diabetes Complications. 1997; 11: 176179.[CrossRef][Medline] [Order article via Infotrieve]
34. Pampfer S, Cordi S, Dutrieux C, Vanderheyden I, Marchand C, De Hertogh R. Interleukin 1 beta mediates the effect of high D-glucose on the secretion of TNF-alpha by mouse uterine epithelial cells. Cytokine. 1999; 11: 500509.[CrossRef][Medline] [Order article via Infotrieve]
35. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokines concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106: 20672072.
36. Warner DS, Smith ML, Siesjo BK. Ischemia in normo- and hyperglycemic rats: effects on brain water and electrolytes. Stroke. 1987; 18: 464471.
37. Paljarvi L, Rehncrona S, Soderfeldt B, Olsson Y, Kalimo H. Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol (Berl). 1983; 60: 232240.[CrossRef][Medline] [Order article via Infotrieve]
38. Chan PH, Schmidley JW, Fishman RA, Longar SM. Brain injury, edema, and vascular permeability changes induced by oxygen derived free radicals. Neurology. 1984; 34: 315320.
39. Wei EP, Ellison MD, Kontos HA, Povlishock JT. O2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am J Physiol. 1986; 251: H693H699.[Medline] [Order article via Infotrieve]
40. Thiel VE, Audus KL. Nitric oxide and blood-brain barrier integrity. Antioxid Redox Signal. 2001; 3: 273278.[CrossRef][Medline] [Order article via Infotrieve]
41. Schilling L, Wahl M. Mediators of cerebral edema. Adv Exp Med Biol. 1999; 474: 123141.[Medline] [Order article via Infotrieve]
42. Plesnila N, Schulz J, Stoffel M, Eriskat J, Pruneau D, Baethmann A. Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats. J Neurotrauma. 2001; 18: 10491058.[CrossRef][Medline] [Order article via Infotrieve]
43. Schulz J, Plesnila N, Eriskat J, Stoffel M, Pruneau D, Baethmann A. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats. Acta Neurchir Suppl. 2000; 76: 137139.
44. Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett. 2000; 283: 230232.[CrossRef][Medline] [Order article via Infotrieve]
45. Gong C, Hoff JT, Keep RF. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000; 871: 5765.[CrossRef][Medline] [Order article via Infotrieve]
46. Massry SG, Smogorzewski M. Role of elevated cytosolic calcium in the pathogenesis of complications in diabetes mellitus. Miner Electrolyte Metab. 1997; 23: 253260.[Medline] [Order article via Infotrieve]
47. Araki N, Greenberg JH, Sladky JT, Uematsu D, Karp A, Reivich M. The effect of hyperglycemia on intracellular calcium in stroke. J Cereb Blood Flow Metab. 1992; 12: 469476.[Medline] [Order article via Infotrieve]
48. Rosenberg GA, Navratil MJ. (S)Emopamil reduced brain edema from collagenase-induced hemorrhage in rats. Stroke. 1994; 25: 20672071.[Abstract]
This article has been cited by other articles:
![]() |
Y.-C. Chuang, Y.-M. Chen, S.-K. Peng, and S.-Y. Peng Risk stratification for predicting 30-day mortality of intracerebral hemorrhage Int. J. Qual. Health Care, December 1, 2009; 21(6): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sykora, J. Diedler, P. Turcani, W. Hacke, and T. Steiner Baroreflex: A New Therapeutic Target in Human Stroke? Stroke, December 1, 2009; 40(12): e678 - e682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. S. Latorre, S. H.-Y. Chou, R. G. Nogueira, A. B. Singhal, B. S. Carter, C. S. Ogilvy, and G. A. Rordorf Effective Glycemic Control With Aggressive Hyperglycemia Management Is Associated With Improved Outcome in Aneurysmal Subarachnoid Hemorrhage Stroke, May 1, 2009; 40(5): 1644 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. James, P. M. Sullivan, C. D. Lascola, M. P. Vitek, and D. T. Laskowitz Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage Stroke, February 1, 2009; 40(2): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Zubkov, J. N. Mandrekar, D. O. Claassen, E. M. Manno, E. F. M. Wijdicks, and A. A. Rabinstein Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage Arch Neurol, October 1, 2008; 65(10): 1320 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study Brain, September 1, 2006; 129(9): 2375 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Frontera, A. Fernandez, J. Claassen, M. Schmidt, H. C. Schumacher, K. Wartenberg, R. Temes, A. Parra, N. D. Ostapkovich, and S. A. Mayer Hyperglycemia After SAH: Predictors, Associated Complications, and Impact on Outcome Stroke, January 1, 2006; 37(1): 199 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M.S. Nys, M. J.E. van Zandvoort, P. L.M. de Kort, H. B. van der Worp, B. P.W. Jansen, A. Algra, E. H.F. de Haan, and L. J. Kappelle The prognostic value of domain-specific cognitive abilities in acute first-ever stroke Neurology, March 8, 2005; 64(5): 821 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Flibotte, N. Hagan, J. O'Donnell, S. M. Greenberg, and J. Rosand Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology, September 28, 2004; 63(6): 1059 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Jung, K. Chu, S.-W. Jeong, S.-Y. Han, S.-T. Lee, J.-Y. Kim, M. Kim, and J.-K. Roh HMG-CoA Reductase Inhibitor, Atorvastatin, Promotes Sensorimotor Recovery, Suppressing Acute Inflammatory Reaction After Experimental Intracerebral Hemorrhage Stroke, July 1, 2004; 35(7): 1744 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lindsberg and R. O. Roine Hyperglycemia in Acute Stroke Stroke, February 1, 2004; 35(2): 363 - 364. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |